Federico Grossi - Jan 14, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ David Watson, attorney-in-fact for Dr. Federico Grossi
Stock symbol
APLS
Transactions as of
Jan 14, 2022
Transactions value $
-$556
Form type
4
Date filed
1/19/2022, 07:03 PM
Previous filing
Jan 14, 2022
Next filing
Jan 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $14.7K +3.4K +4.5% $4.31* 78.9K Jan 14, 2022 Direct
transaction APLS Common Stock Sale -$15.2K -375 -0.48% $40.56 78.5K Jan 14, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -3.4K -4.94% $0.00 65.4K Jan 14, 2022 Common Stock 3.4K $4.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled sale from 10B5-1 trading plan.
F2 This stock option was granted on 08/21/2017 and is fully vested.